Stay updated on Nivolumab Post Induction in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Post Induction in NSCLC Clinical Trial page.

Latest updates to the Nivolumab Post Induction in NSCLC Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRevision: v3.3.2 is shown on the page, replacing v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedRemoved the temporary government funding/status notice from the page; the study details remain unchanged.SummaryDifference0.4%

- Check43 days agoChange DetectedNo additions or deletions detected for the page. The content and layout remain unchanged.SummaryDifference0.5%

- Check72 days agoChange DetectedUpdated operating-status notice and version to v3.2.0, replacing the previous v3.1.0.SummaryDifference3%

- Check79 days agoChange DetectedUpdated contact details and updated revision to v3.1.0; removed old revision v3.0.2.SummaryDifference0.1%

- Check93 days agoChange DetectedThe page revision updates from v3.0.1 to v3.0.2, and the 'Back to Top' element has been removed.SummaryDifference0.2%

Stay in the know with updates to Nivolumab Post Induction in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Post Induction in NSCLC Clinical Trial page.